JP7063487B2 - ピラン縮合環系化合物、その製造方法及び使用 - Google Patents

ピラン縮合環系化合物、その製造方法及び使用 Download PDF

Info

Publication number
JP7063487B2
JP7063487B2 JP2019566842A JP2019566842A JP7063487B2 JP 7063487 B2 JP7063487 B2 JP 7063487B2 JP 2019566842 A JP2019566842 A JP 2019566842A JP 2019566842 A JP2019566842 A JP 2019566842A JP 7063487 B2 JP7063487 B2 JP 7063487B2
Authority
JP
Japan
Prior art keywords
formula
compound represented
compound
reacting
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019566842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020521806A (ja
Inventor
徐為平
Original Assignee
北京天一緑甫医葯科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京天一緑甫医葯科技有限公司 filed Critical 北京天一緑甫医葯科技有限公司
Publication of JP2020521806A publication Critical patent/JP2020521806A/ja
Application granted granted Critical
Publication of JP7063487B2 publication Critical patent/JP7063487B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2019566842A 2018-03-02 2019-03-01 ピラン縮合環系化合物、その製造方法及び使用 Active JP7063487B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810176172 2018-03-02
CN201810176172.2 2018-03-02
PCT/CN2019/076757 WO2019166019A1 (zh) 2018-03-02 2019-03-01 吡喃稠环类化合物、其制备方法和用途

Publications (2)

Publication Number Publication Date
JP2020521806A JP2020521806A (ja) 2020-07-27
JP7063487B2 true JP7063487B2 (ja) 2022-05-09

Family

ID=67805659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019566842A Active JP7063487B2 (ja) 2018-03-02 2019-03-01 ピラン縮合環系化合物、その製造方法及び使用

Country Status (5)

Country Link
US (1) US11396515B2 (zh)
EP (1) EP3608323B1 (zh)
JP (1) JP7063487B2 (zh)
CN (1) CN110218213B (zh)
WO (1) WO2019166019A1 (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501715A (ja) 2004-06-03 2008-01-24 エーザイ株式会社 ハリコンドリンbの調製用中間体
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
JP2016536316A (ja) 2013-11-04 2016-11-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
WO2017168309A1 (en) 2016-03-29 2017-10-05 Dr. Reddy’S Laboratories Limited Process for preparation of eribulin and intermediates thereof
WO2018006031A1 (en) 2016-06-30 2018-01-04 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501715A (ja) 2004-06-03 2008-01-24 エーザイ株式会社 ハリコンドリンbの調製用中間体
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
JP2016536316A (ja) 2013-11-04 2016-11-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
WO2017168309A1 (en) 2016-03-29 2017-10-05 Dr. Reddy’S Laboratories Limited Process for preparation of eribulin and intermediates thereof
WO2018006031A1 (en) 2016-06-30 2018-01-04 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LI, J. et al.,Unified Synthesis of C1-C19 Building Blocks of Halichondrins via Selective Activation/Coupling of Polyhalogenated Nucleophiles in (Ni)/Cr-Mediated Reactions,Journal of the American Chemical Society,2015年,137(19),pp. 6226-6231
YAN, W. et al.,Selective Activation/Coupling of Polyhalogenated Nucleophiles in Ni/Cr-Mediated Reactions: Synthesis of C1-C19 Building Block of Halichondrin Bs,Journal of the American Chemical Society,2015年,137(19),pp. 6219-6225

Also Published As

Publication number Publication date
EP3608323A4 (en) 2020-06-03
WO2019166019A1 (zh) 2019-09-06
US11396515B2 (en) 2022-07-26
CN110218213A (zh) 2019-09-10
EP3608323B1 (en) 2021-11-03
US20220048921A1 (en) 2022-02-17
EP3608323A1 (en) 2020-02-12
JP2020521806A (ja) 2020-07-27
CN110218213B (zh) 2020-09-04

Similar Documents

Publication Publication Date Title
EP3002285B1 (en) Tetrahydrocarboline derivative
CA2857395A1 (en) Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
TW201514159A (zh) 3-((2s,5s)-4-亞甲基-5-(3-氧代丙基)四氫呋喃-2-基)丙醇衍生物、其製備及對其有用的中間體
EP2669279B1 (en) Bicyclic compound and use thereof for medical purposes
JP7063487B2 (ja) ピラン縮合環系化合物、その製造方法及び使用
JP6212429B2 (ja) 1,3,4,5−テトラカフェオイルキナ酸の製造方法および中間体化合物
CA2708143C (en) Intermediates in the synthesis of zearalenone macrolide analogs
AU2014229065A1 (en) Methods of synthesizing a difluorolactam analog
US6555559B1 (en) 5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same
AU3270299A (en) C11oxymyl and hydroxylamino prostaglandins useful as FP agonists
WO2014094511A1 (zh) 一种制备曲前列尼尔的中间体、其制备方法以及通过其制备曲前列尼尔的方法
WO2009158381A1 (en) Novel psymberin derivatives, compositions, and their use as antineoplastic agents
EP3686208B1 (en) Intermediates for preparing halichondrin compounds and preparation method therefor
CN107266303B (zh) 合成方法
WO2020216034A1 (zh) 艾日布林的中间体及其合成方法和用途
JP4523761B2 (ja) 抗腫瘍活性を有する新規化合物、およびその製造方法
TWI520956B (zh) 伊莎匹隆及其中間體之製備方法
WO2000053578A1 (fr) Derives de la vitamine d et leur procede de preparation
JP2004315373A (ja) 抗腫瘍活性および血管新生阻害活性を有する化合物、ならびにその製造方法
JP2004035497A (ja) デカヒドロ−2H−ベンゾ[a]キサンテン−3,11−ジオール誘導体およびその製造中間体
WO2005035489A2 (en) Improved synthesis of discodermolide and variants thereof
JPWO2009093463A1 (ja) 神経細胞死抑制剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191128

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191128

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20201119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220414

R150 Certificate of patent or registration of utility model

Ref document number: 7063487

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150